FDA Rule Requiring Breast Density Notices With Every Mammogram Takes Effect
Mahan Court, FDA White Oak Campus, White Oak, Montgomery County, Maryland, 20993, United States
U.S. Food and Drug Administration
CONFIRMED89% CONFIDENCEThe FDA[1] page says "Enforcement of the MQSA regulations as amended by the 2023 MQSA Final Rule began on September 10, 2024"; the rule has no end date, so the period is open-ended.
Every US mammography facility must now tell patients in writing whether their breast tissue is dense, which can hide cancers on a mammogram, under the FDA's amended Mammography Quality Standards Act rule.
1.00